A Single Center, Randomized, Double-blind Controlled Trial of Sitagliptin Versus Placebo to Reduce the Incidence and Severity of New-onset Diabetes After Kidney Transplant
Phase of Trial: Phase II
Latest Information Update: 07 Nov 2016
At a glance
- Drugs Sitagliptin (Primary)
- Indications Diabetes mellitus
- Focus Therapeutic Use
- 31 Oct 2016 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 31 Oct 2016 Planned primary completion date changed from 1 Jul 2017 to 1 Jun 2018.
- 12 Nov 2015 Planned End Date changed from 1 Jun 2017 to 1 Dec 2017 as reported by ClinicalTrials.gov record.